Epilepsy is characterized by recurrent unprovoked seizures caused by abnormal neuronal activity in the brain. Key questions in evaluating epilepsy include determining seizure type, identifying underlying causes or syndromes, selecting appropriate anti-epileptic drug treatment, and determining criteria for stopping treatment or pursuing surgical options. Diagnosis involves a detailed history and examination, as well as EEG and potentially MRI to classify the epilepsy syndrome and guide management.
Neuropsychiatric manifestations of endocrine disordersDheeraj kumar
This is a subject seminar of neuropsychiatric manifesations of endocrine disorders.It took a lot of time to prepare,it helps fellow residents of Gen medicine to download and present as it is.
Vertigo is a subtype of dizziness in which a patient inappropriately experiences the perception of motion (usually a spinning motion) due to dysfunction of the vestibular system.
Neuropsychiatric manifestations of endocrine disordersDheeraj kumar
This is a subject seminar of neuropsychiatric manifesations of endocrine disorders.It took a lot of time to prepare,it helps fellow residents of Gen medicine to download and present as it is.
Vertigo is a subtype of dizziness in which a patient inappropriately experiences the perception of motion (usually a spinning motion) due to dysfunction of the vestibular system.
Movement disorders are not only realm of chronic disorders that are treated without requiring emergent intervention, but also they can present acutely with more aggressive forms
Movement disorders are not only realm of chronic disorders that are treated without requiring emergent intervention, but also they can present acutely with more aggressive forms
6. Seizure type
Partial-
Simple- no LOC
Complex- focal onset with LOC
Secondary generalization
Generalized- all have LOC
Tonic, clonic, tonic-clonic-grand mal
Absence-petit mal
Atonic
Myoclonic
9. Investigation
Glucose, Electrolytes, Calcium, Creatinine
12 lead ECG
MRI- to identify structural abnormalities, if
Onset <2 years or adulthood
Focal onset by history, examination, EEG
Refractory seizures
EEG-
Helps support diagnosis of epilepsy
Helps determine seizure type/epilepsy syndrome
Helps determine risk of recurrence
Supported by sleep EEG, photic stimulation & hyperventilation
10. Treatment
AED- anti-epileptic drugs
Goals- no seizures & no side-effects
Monotherapy preferred
Single AED effective in ~50%
~70% controlled with 2 drugs
~20% have breakthrough seizures despite
best AEDs
Vagus nerve stimulation as adjunct in
refractory epilepsy, not for surgery
11. When to start AED?
Generally after 2nd
seizure- recurrence ~75%
After 1st
seizure (recurrence ~1/3rd
)- if
Individual has neurological deficit
EEG shows unequivocal epileptic activity
Brain imaging shows a structural abnormality
Unacceptable risk of recurrence
Some choose not to take AEDs after knowing all
risks & benefits
12. What first-line AED?
GTC- carbamazepine-C, lamotrigine-L,
Na valproate-V, topiramate-T
Absence- ethosuximide-E, L, V
Myoclonic- V
Tonic- L, V
Atonic- L, V
Partial- C, L, V, T
13. When to stop?
A collective decision based on epilepsy
syndrome, prognosis, lifestyle
Withdrawl only after 2 years of seizure free
period
One drug at a time, withdrawn over 2-3
months
Benzodiazepines & barbiturates withdrawl
may cause withdrawl symptoms
Seizure recurrenceback to last dose
15. Status epilepticus
Seizures without recovery of consciousness
in between
~20% mortality
Commonest cause- poor compliance with
AED
Ensure A.B.C
Rx- Lorazepam/Diazepam(Fos)Phenytoin
Once controlled- find cause &
institute long-term AEDs
16. Women & epilepsy
Women on AED planning pregnancy- folic
acid supplementation
Teratogenicity- maximum with Na valproate
Pregnant woman on AED- US at 18-20 weeks
to detect structural fetal defects
Ensure compliance with AED to avoid a
seizure during pregnancy
Do not change an effective AED
Breast-feeding to be encouraged